The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world evidence of cardiac hospitalizations in carfilzomib- and non-carfilzomib-treated multiple myeloma patients in the United States.
 
Joseph Mikhael
Research Funding - Abbvie (Inst); Celgene (Inst); Sanofi (Inst)
 
Khalid Mezzi
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Karim Iskander
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Kenneth Wang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Christopher Kim
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Shao Zhu
Employment - Novartis (I)
Consulting or Advisory Role - Amgen
 
Megan Braunlin
Employment - Amgen
 
Winifred A. Werther
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Ajai Chari
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Array Biopharma; Bayer; Celgene; Janssen Oncology; Millennium; Novartis; Seagen
Research Funding - Acetylon Pharmaceuticals (Inst); Array BioPharma; Biotest (Inst); Bristol-Myers Squibb (Inst); Celgene; Janssen; Millennium; Novartis; Onyx; Pharmacyclics
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Takeda